Why the study?
What is the survival and tissue distribution of 111Indium-oxine labelled autologous platelets in asplenic subjects?
What is the survival and tissue distribution of 111Indium-oxine labelled autologous platelets in asplenic subjects?
This study demonstrates that in the absence of a spleen, senescent platelets are primarily destroyed in the liver and bone marrow, exhibiting a linear survival curve.
Answers are grounded in this paper and cite their sources.
Platelet kinetics in asplenia warrant cautious clinical use; leaves open validation of liver and marrow clearance in larger studies.
The survival, tissue distribution and fate of (111)Indium-oxine labelled autologous platelets was studied in four asplenic subjects with serial blood sampling, scintillation camera and computer-assisted imaging. Mean (111)In-platelet recovery in the circulation was 89 /+- 13% (/+- 1 SD). Platelet survival curves fitted a linear function best and was 238 /+0 41 h. The shape of the survival curves of normal and asplenic subjects differed: in the asplenic subjects the curve was linear whereas that of normal subjects was significantly more curvilinear if analyzed by least squares computer fitting to a gamma function. Early hepatic (111)In-activity was significant and transient and ascribed to the "collection injury". As labelled platelets disappeared from the circulation, (111)In-activity in the liver increased progressively and linearly to reach 42.5 /+- 14.1% of whole body activity at 240 h. Radioactivity also accumulated in the bone marrow, but could not be demonstrated in the vasculature of the lower limbs. These results would indicate that in asplenic subjects the majority sites of destruction of senescent platelets are the liver and bone marrow.
No takes yet. Share an insight, caveat, or question.
Heyns et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: